Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China · Delayed Price · Currency is CNY 13.34
-0.39 (-2.84%)
May 20, 2026, 1:35 PM CST
SHE:300401 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 258.62 | 304.86 | 309.21 | 192.35 | 383.72 | 483.77 |
Depreciation & Amortization | 178.15 | 178.15 | 155.84 | 133.36 | 60.98 | 44.59 |
Other Amortization | 0.25 | 0.25 | - | - | - | - |
Loss (Gain) From Sale of Assets | 2.24 | 2.24 | -31.53 | 0.04 | -17.8 | -76.22 |
Asset Writedown & Restructuring Costs | 0.21 | 0.21 | 0.19 | 0.28 | 1.01 | 0.09 |
Loss (Gain) From Sale of Investments | -1.41 | -1.41 | -0.72 | 0.27 | -1.45 | -4.63 |
Provision & Write-off of Bad Debts | 2.12 | 2.12 | 1.95 | -2.39 | 2.53 | 0.32 |
Other Operating Activities | 138.87 | 37.07 | 33.85 | 52.57 | 20.43 | 41.35 |
Change in Accounts Receivable | -132.19 | -132.19 | -35.7 | 113.38 | -140.76 | -47.29 |
Change in Inventory | 86.14 | 86.14 | -60.38 | -234.77 | -116.05 | -106.11 |
Change in Accounts Payable | -8.04 | -8.04 | 77.37 | -98.6 | 184.45 | 165.15 |
Change in Other Net Operating Assets | 2.26 | 2.26 | 20.51 | 28.78 | 7.91 | 0.82 |
Operating Cash Flow | 530.3 | 474.74 | 466.41 | 159.98 | 377.04 | 512.25 |
Operating Cash Flow Growth | 6.19% | 1.79% | 191.53% | -57.57% | -26.40% | 19.85% |
Capital Expenditures | -333.23 | -361.96 | -480.38 | -244.55 | -379.93 | -715.58 |
Sale of Property, Plant & Equipment | 0.93 | 0.93 | 29.31 | 0.68 | 12.52 | 114.44 |
Cash Acquisitions | - | - | - | -93.33 | - | -790.01 |
Investment in Securities | -13.33 | -253.33 | -233.33 | 24.16 | -0.08 | 200 |
Other Investing Activities | 6.25 | 4.2 | -9.78 | -31.43 | -4.67 | 4.63 |
Investing Cash Flow | -339.38 | -610.16 | -694.18 | -344.47 | -372.15 | -1,186 |
Short-Term Debt Issued | - | - | - | - | 933.58 | 493.37 |
Long-Term Debt Issued | - | 1,127 | 1,226 | 2,285 | - | - |
Total Debt Issued | 1,308 | 1,127 | 1,226 | 2,285 | 933.58 | 493.37 |
Short-Term Debt Repaid | - | - | - | - | -818.35 | -414.45 |
Long-Term Debt Repaid | - | -1,153 | -1,138 | -962.97 | - | -0.19 |
Total Debt Repaid | -923.2 | -1,153 | -1,138 | -962.97 | -818.35 | -414.64 |
Net Debt Issued (Repaid) | 384.8 | -26.1 | 87.62 | 1,322 | 115.23 | 78.72 |
Issuance of Common Stock | - | - | - | - | 53.72 | 3.5 |
Repurchase of Common Stock | - | - | -13.27 | -86.74 | - | - |
Common Dividends Paid | -97.97 | -92.15 | -67.39 | -103.08 | -122.74 | -65.99 |
Other Financing Activities | -90 | -90 | 100.7 | -92.3 | -2.23 | -28.77 |
Financing Cash Flow | 196.83 | -208.25 | 107.66 | 1,040 | 43.99 | -12.53 |
Foreign Exchange Rate Adjustments | -7.16 | 0.53 | 4.15 | 3.47 | 1.91 | -1.43 |
Net Cash Flow | 380.59 | -343.14 | -115.97 | 859.32 | 50.79 | -687.57 |
Free Cash Flow | 197.07 | 112.78 | -13.97 | -84.57 | -2.89 | -203.33 |
Free Cash Flow Margin | 16.59% | 9.11% | -1.12% | -7.72% | -0.20% | -18.20% |
Free Cash Flow Per Share | 0.33 | 0.19 | -0.02 | -0.14 | -0.01 | -0.37 |
Cash Income Tax Paid | 48.42 | 51.51 | 54.3 | 3.08 | 81.87 | 76.06 |
Levered Free Cash Flow | -26.52 | -161.25 | -201.17 | -303.71 | -6.59 | -426.66 |
Unlevered Free Cash Flow | -6.58 | -140.95 | -178.9 | -279.7 | 7.05 | -419.9 |
Change in Working Capital | -48.76 | -48.76 | -2.38 | -216.5 | -72.39 | 22.98 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.